Astodrimer sodium

阿斯君默钠

Report date: 2025/05/22 16:59:57
NMEQIDP

Base Information

Drug NameAstodrimer sodium
Drug Alias Name阿斯君默钠阴道生物性黏附凝胶3% w/w SPL7013 GelSPL7013 vaginal gelVivaGelFleurstat BV +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnvelope glycoprotein gp160 inhibitors
TargetsEnvelope glycoprotein gp160
Therapy Area/IndicationsHIV InfectionsVaginosis, Bacterial
Global Approved IndicationsVaginosis, Bacterial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2017/10/25
Country/TerritoryCzechiaBulgariaCanada +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiomolecular Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesStarpharma Holdings Ltd
Inactive CompaniesStarpharma Pty Ltd
Active IndicationsVaginosis, Bacterial
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksDrugBank